Login – Integrity CE
Username* Password* Remember me Register | Forgot Password
Related Articles
De-Escalation Strategies With Immune Checkpoint Blockers in NonāSmall Cell Lung Cancer: Do We Already Have Enough Evidence?
Immune checkpoint blockers (ICBs) have revolutionized the treatment of nonāsmall cell lung cancer (NSCLC). Currently, one-dose-fits-all maximalist regimens have been considered the standard of care,…
Kiss of death between CARāT cells and KMT2a::AFF1 B lymphoblasts in the central nervous system
The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.
Whole-body deodorants: a solution to a non-existent problem
Marketers want us to be worried about smelly intimate parts. The thing is, they are mostly self-cleaning.
Dr. Shereef Elnahal – U.S. Department of Veterans Affairs
Dr. Shereef Elnahal was appointed by President Joseph R. Biden to serve as Under Secretary for Health at the Department of Veterans Affairs (VA) and…
The White House
President Biden and Vice President Harris promised to move quickly to deliver results for working families. Thatās what theyāve done.
How I Treat Anemia in Myelofibrosis
Anemia is a common consequence of myelofibrosis. The treatment of myelofibrosis-associated anemia is complicated by a multifactorial pathobiology, as well
Trump Team Taps Dr. Matthew J. Memoli as Acting NIH Director, to Control Political Games and Push Aside Lawrence Tabak
Future NIH changes likely as transition team plans to move out senior officials who have been caught politicizing science and misleading the public.
Ali Dzhemiliev: Impressive talk by Nelya Melnitchouk at 20th-anniversary celebration of the CSPH – OncoDaily
Ali Dzhemiliev: Impressive talk by Nelya Melnitchouk at 20th-anniversary celebration of the CSPH / Ali Dzhemiliev, Brigham and Women’s Hospital, cancer,
Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment
npj Digital Medicine – Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment
Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell lines – PubMed
The results suggest that treatment of castrate-resistant prostate cancer by imipridones may not be substantially affected by neuroendocrine differentiation as a therapy-resistance mechanism. The results…